BIOCON Fact Sheet, BIOCON Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

BIOCON Fact Sheet    (BICN)

LAST CHANCE: See How Richa Picks Potentially Crorepati-Making Stocks... for FREE!

Here is the latest financial fact sheet of BIOCON . For more details, see the BIOCON quarterly results and BIOCON share price and chart. For a sector overview, read our pharmaceuticals sector report.

BIOCON Price History

Price Rs 376.6
Mkt Cap Rs m 452,146
Vol '000 312.0
P/E X 48.7
P/CF X 27.6
EPS (TTM) Rs 7.7
1 Day % 3.5
No. of shares m 1,200.60
1 Week % 1.8
1 Month % 7.1
1 Year % -16.3
52 week H/L Rs 456.0/314.9
As on Jan 21, 2022 (Close)
* Results Consolidated

BIOCON Financials

No. of Mths
Year Ending
5-Yr Chart
Click to enlarge
High Rs1,1621,188718636488 
Low Rs482305544211275 
Sales per share (Unadj.) Rs193.068.691.952.559.2 
Earnings per share (Unadj.) Rs33. 
Diluted earnings per shareRs5. 
Cash flow per share (Unadj.) Rs47.513.624.212.113.7 
Dividends per share (Unadj.) Rs3.001.001.0000 
Adj. dividends per shareRs0.500.500.500.000.00 
Avg Dividend yield % 
Book value per share (Unadj.) Rs238.585.2100.355.062.3 
Adj. book value per shareRs39.742.650.154.962.2 
Shares outstanding (eoy) m200.00600.00600.001,200.001,200.00 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x4.310. 
Avg P/E ratio x24.5103.737.856.549.4 
P/CF ratio (eoy) x17.354.826.135.027.9 
Price / Book Value ratio x3. 
Dividend payout %8.913.96.000 
Avg Mkt Cap Rs m164,430447,900378,645508,380457,350 
No. of employees `000NANANANANA 
Total wages/salary Rs m7,4709,31111,65314,58817,410 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
Net Sales Rs m38,60641,17155,14463,00571,058 
Other income Rs m1,5712,0624,1435,0756,052 
Total revenues Rs m40,17743,23359,28768,08077,110 
Gross profit Rs m9,7958,29113,18413,24513,145 
Depreciation Rs m2,7723,8514,4785,5227,151 
Interest Rs m260615709649577 
Profit before tax Rs m8,3345,88712,14012,14911,469 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,6161,5692,1233,1512,215 
Profit after tax Rs m6,7184,31810,0178,9989,254 
Gross profit margin %25.420.123.921.018.5 
Effective tax rate %19.426.717.525.919.3 
Net profit margin %17.410.518.214.313.0 
Current assets Rs m40,47741,48648,88553,25076,004 
Current liabilities Rs m16,78321,41330,38540,08042,101 
Net working cap to sales %61.448.833.520.947.7 
Current ratio x2. 
Inventory Days Days1651119583137 
Debtors Days Days8494867163 
Net fixed assets Rs m51,49056,47769,79287,508106,142 
Share capital Rs m1,0003,0003,0006,0006,000 
"Free" reserves Rs m46,70248,12357,20859,97068,728 
Net worth Rs m47,70251,12360,20865,97074,728 
Long term debt Rs m21,08217,89815,25612,22229,616 
Total assets Rs m91,96797,963118,677140,758182,146 
Interest coverage x33.110.618.119.720.9 
Debt to equity ratio x0. 
Sales to assets ratio x0. 
Return on assets % 
Return on equity %14.18.416.613.612.4 
Return on capital %12.59.417.016.411.5 
Exports to sales %00000 
Imports to sales %20.517.818.913.47.2 
Exports (fob) Rs m00000 
Imports (cif) Rs m7,8997,34810,3998,4745,084 
Fx inflow Rs m12,98812,05815,50611,75311,791 
Fx outflow Rs m7,8997,34810,3998,4745,084 
Net fx Rs m5,0894,7105,1073,2796,707 
From Operations Rs m 6,400 6,621 11,546 12,831 11,597 
From Investments Rs m -4,985 -6,840 -7,138 -15,589 -36,247 
From Financial Activity Rs m -1,775 -2,397 -2,417 3,876 25,640 
Net Cashflow Rs m -473 -2,612 2,103 1,654 723 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 60.6%
Institution 23.4%
Non-Institution 16.0%
Total 100.0%
Free Float 39.4%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021

Company Information

Regd Off 20th Km, Hosur Road, Electronic City, Bengaluru - 560100
E-mail Web
Tel 080 2808 2808 Fax 080 2852 3423
Sector PHARMACEUTICALS Group Private sector
Tr Agent K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar Shaw (MD) COMP SEC: Kiran Kumar YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): -

Read: BIOCON 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    


Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Views on news

BIOCON Announces Quarterly Results (2QFY22); Net Profit Up 4.9% (Quarterly Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

For the quarter ended September 2021, BIOCON has posted a net profit of Rs 2 bn (up 4.9% YoY). Sales on the other hand came in at Rs 18 bn (up 5.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of BIOCON for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of BIOCON . Also includes updates on the valuation of BIOCON .

BIOCON Announces Quarterly Results (1QFY22); Net Profit Down 4.0% (Quarterly Result Update)

Jul 26, 2021 | Updated on Jul 26, 2021

For the quarter ended June 2021, BIOCON has posted a net profit of Rs 2 bn (down 4.0% YoY). Sales on the other hand came in at Rs 18 bn (up 3.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms